Table 1 Indicators used to describe and evaluate included randomised controlled trials
From: An assessment of the quality of randomised controlled trials conducted in China
Indicator | Â | Description |
|---|---|---|
Descriptive indicators | ||
1 | Publication language | Chinese or English |
2 | Nationality of authors | Chinese, international or collaboration |
3 | Funding source | As reported |
4 | Disease area | Simple categories |
5 | Choice of comparator interventions | Placebo/alternative treatment/no treatment |
6 | Size of trial | Number of participants |
7 | Ethical committee approval | Yes/No |
8 | Informed consent from participants | As reported |
Quality of reporting: CONSORT indicators | ||
9 | Sample size | How was sample size determined? |
10 | Randomisation | Was the trial randomised? |
11 | Allocation concealment | What method was used to implement the random allocation sequence? |
12 | Blinding | Whether or not patients and/or investigators were blinded to group assignment |
13 | Baseline characteristics | Were the baseline demographic and clinical characteristics of each group reported |
14 | Primary outcomes | Did they report which outcome was designated as the primary outcome? |
15 | Length of follow-up | As reported |
16 | Loss to follow-up | As reported |
17 | Statistical reporting | Were confidence intervals or p values reported to indicate precision? |